Boston, MA -- (SBWIRE) -- 01/28/2014 -- At winstonsmallcap.com we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. Let have a Look on: Sequenom, Inc.(NASDAQ:SQNM), Homex Development Corp. (ADR)(NYSE:HXM), Idera Pharmaceuticals Inc(NASDAQ:IDRA), Coronado Biosciences Inc(NASDAQ:CNDO)
Sequenom, Inc.(NASDAQ:SQNM) opened its shares at the price of $2.41 for the day. Its closing price was $2.30 after losing -3.77% for the day. The company traded with the total volume of 2.40 million shares, while its average trading volume remained 2.17 million shares. The beta of SQNM stands at 0.40. Sequenom, Inc., a life sciences company, provides genetic analysis solutions in the United States and internationally. It operates through two segments, Molecular Diagnostics and Genetic Analysis.
Has SQNM Found The Bottom and Ready To Move Up? Find Out Here
Homex Development Corp. (ADR)(NYSE:HXM) percentage change surged +15.33% to close at $1.58 with the total traded volume of 2.23 million shares, and average volume of 658,767.00. The 52 week range of the stock remained $1.08 - $14.96, while its day lowest price was $1.40 and it hit its day highest price at $1.68. Desarrolladora Homex, S.A.B. de C.V., a vertically integrated home development company, engages in the development, construction, and sale of affordable entry-level, middle-income, and tourism housing in Mexico, as well as affordable entry-level housing in Brazil.
For How Long HXM’s Gloss will Attract Investors ? Find out via this report
Idera Pharmaceuticals Inc(NASDAQ:IDRA) started its trading session with the price of $4.03 and closed at $3.71 by scoring -7.71%. IDRA’s stocks traded with total volume of 2.16 million shares, while the average trading volume remained 2.83 million shares. The beta of IDRA stands at 2.03. Day range of the stock was $3.56 -$4.13. Idera Pharmaceuticals, Inc., a clinical stage biotechnology company, engages in the discovery and development of novel synthetic DNA- and RNA- based drug candidates.
Why Should Investors Buy IDRA After the Recent Fall? Just Go Here and Find Out
Coronado Biosciences Inc(NASDAQ:CNDO) ended its day with the loss of -3.91% and closed at the price of $2.70 after opening at $2.86. Stock traded during its last trading session with the total volume of 2.15 million shares, as compared to its average volume of 2.60 million shares. Coronado Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on the development of immunotherapy biologic agents for the treatment of autoimmune diseases and cancer.
Will CNDO Get Buyers Even After The Recent Rally? Find Out Here
Here at Winston we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. We focus on companies that we feel are trading at a discount to the market for various reasons. Enter your email and track our performance! We are sure you won’t be disappointed.
http://winstonsmallcap.com/ and its owners, and their affiliates, directors and officers, and immediate family members, are hereafter collectively referred to as “WSC” or “we” or “us” or “our”). WSC publishes information (the “Information”) about publicly traded companies (the “Profiled Company” or the “Profiled Companies”) which has been obtained from various sources including publicly available sources on the internet. WSC does not undertake any due diligence or investigation of the Information it obtains or publishes.
Read Full Disclaimer at: http://winstonsmallcap.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)